BCR/ABL- CD34(+)HLA-DR- progenitor cells in early chronic phase, but not in more advanced phases, of chronic myelogenous leukemia are polyclonal.
第一作者:
M,Delforge
第一单位:
Division of Hematology, the Department of Medicine, University Hospital Gasthuisberg, Leuven, Belgium. Michel.Delforge@uz.kuleuven.ac.be
作者:
医学主题词
成年人(Adult);抗原, CD34(Antigens, CD34);骨髓细胞(Bone Marrow Cells);细胞, 培养的(Cells, Cultured);克隆细胞(Clone Cells);女(雌)性(Female);融合蛋白质类, bcr-abl(Fusion Proteins, bcr-abl);基因, abl(Genes, abl);HLA-DR抗原(HLA-DR Antigens);造血干细胞(Hematopoietic Stem Cells);人类(Humans);白血病, 髓样(Leukemia, Myeloid);聚合酶链反应(Polymerase Chain Reaction);时间因素(Time Factors)
PMID
9864172
发布时间
2021-02-16
- 浏览15
Blood
284-92页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



